We are live on ! Find out more
AGRX

Agile Therapeutics

Delisted

AGRX was delisted on the 25th of March, 2024.

76 hedge funds and large institutions have $116M invested in Agile Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $641K | Put options by funds: $214K

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 7576 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less capital invested

Capital invested by funds: $118M → $116M (-$2.06M)

Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
22
Reduced
15
Closed
10
Calls
$641K
Puts
$214K
Net Calls
+$427K
Net Calls Change
-$640K
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
26
Squarepoint
New York
$330K +$336K +57 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$294K
DBIA
28
Dumont & Blake Investment Advisors
New Jersey
$287K
Citadel Advisors
29
Citadel Advisors
Florida
$280K +$76.5K +13 +36%
State of Wisconsin Investment Board
30
State of Wisconsin Investment Board
Wisconsin
$275K +$283K +48 New
RA
31
Royce & Associates
New York
$258K
Group One Trading
32
Group One Trading
Illinois
$246K
Thrivent Financial for Lutherans
33
Thrivent Financial for Lutherans
Minnesota
$206K -$53K -9 -20%
Morgan Stanley
34
Morgan Stanley
New York
$206K +$124K +21 +140%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$200K +$17.7K +3 +9%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$179K
AQR Capital Management
37
AQR Capital Management
Connecticut
$178K +$11.8K +2 +7%
Deutsche Bank
38
Deutsche Bank
Germany
$148K +$41.2K +7 +37%
Ameriprise
39
Ameriprise
Minnesota
$144K -$35.3K -6 -19%
AllianceBernstein
40
AllianceBernstein
Tennessee
$137K
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$131K +$94.2K +16 +229%
Principal Financial Group
42
Principal Financial Group
Iowa
$103K +$23.5K +4 +29%
VOYA Investment Management
43
VOYA Investment Management
Georgia
$92K +$23.5K +4 +33%
GC
44
Grimes & Company
Massachusetts
$86K
RJA
45
Raymond James & Associates
Florida
$81K
Creative Planning
46
Creative Planning
Kansas
$78K
NAM
47
Nexpoint Asset Management
Texas
$72K
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$69K
CS
49
Credit Suisse
Switzerland
$64K +$64.7K +11 New
Barclays
50
Barclays
United Kingdom
$63K +$64.7K +11 New

AGRX Hedge Fund Activity: Q4 2020 in Review

76 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q4 2020, worth a combined $116M — down 1.7% from $118M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AGRX positions and 10 closed out — a net gain of 1 holder — while 22 added to existing stakes and 15 trimmed.

The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $2.05M. The largest seller was DG Capital Management, cutting an estimated $2.55M.

  • 76 institutional investors held Agile Therapeutics (AGRX) as of Q4 2020, up from 75 in Q3 2020.
  • Funds reported $116M of Agile Therapeutics stock for Q4 2020, down 1.7% quarter-over-quarter.
  • 11 funds opened new Agile Therapeutics positions in Q4 2020 and 10 closed out, a net change of +1 holder.
  • The largest Agile Therapeutics buyer in Q4 2020 was Manulife (Manufacturers Life Insurance), an estimated $2.05M added.
  • The largest Agile Therapeutics seller in Q4 2020 was DG Capital Management, an estimated $2.55M sold.

Based on aggregated 13F filings for Q4 2020.